Nanopore direct RNA sequencing
Reading native RNA molecules strand by strand through a protein nanopore — no reverse transcription, no amplification bias, base modifications visible in the raw current. Two ledger-backed rows; the sequencing-services layer belongs to the sibling page.
1 · What it gives
Direct RNA sequencing reads an RNA molecule the way it exists in the cell: the native strand passes through a protein nanopore, each base disturbs an ionic current, and the current trace is decoded into sequence. Because the molecule is never reverse-transcribed into cDNA and never amplified, the two distortions that shape most transcriptomics disappear — reverse-transcription bias, which under- and over-represents transcripts, and PCR amplification, which erases the chemical record. That chemical record is the platform’s distinctive output: base modifications such as m6A leave characteristic current signatures, so modification mapping runs on the same read that gives the sequence, not on a separate chemistry. The corpus’s ledger evidence pairs a chemistry owner with a deployment. Oxford Nanopore owns the platform end: the UK-listed sequencing company (LSE: ONT) runs production at the Harwell Campus in Didcot and the Spectrum facility in Abingdon, builds more than a million flow cells a year, manufactures under ISO 13485, and marks its GridION Dx configuration CE-IVD and UKCA — the regulated edge of a research-first chemistry. Genoscope owns a deployment end: the French national sequencing centre runs nanopores for real-time surveillance of ocean and soil metagenomes, with the nanoMDBG metagenome assembly as its published instrument and the €41.3 million ATLASea program (2024) as its marine-genome mandate. The boundary against sibling pages: long-read-sequencing-services owns the service layer and the PromethION DNA long-read row; spatial-transcriptomics owns measurement geometry; bioinformatics-multi-omics owns the downstream analysis. This page owns the native-RNA chemistry itself.
Key directions of nanopore direct RNA sequencing:
- Native-RNA chemistry (No Conversion): the strand is read as RNA, so reverse-transcription bias and amplification distortion never enter the measurement.
- Modification-aware reads (Chemistry as Signal): m6A-class base modifications appear in the raw ionic current, making modification mapping a property of the read rather than a separate assay.
- Real-time environmental surveillance (Nanopores in the Field): Genoscope’s ocean and soil metagenome monitoring, assembled through nanoMDBG, runs sequencing as a live instrument rather than a batch service.
- Isoform-resolved transcriptomics (Full-Length Reads): full-length strand reads resolve isoforms directly, with barcode-aware adaptive sampling and an updated cDNA-PCR kit extending the platform’s transcriptomic reach.
Sectoral value chain#
[native RNA sample] ──> [direct-RNA library prep] ──> [pore flow cell]
│
(live basecalling, modifications)
▼
[surveillance / transcriptomics] <── [real-time analysis] <── [current-trace reads]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Native extraction | intact RNA recovered without degradation | In: biological sample. Out: full-length RNA. |
| Library preparation | adapters ligated to native strands | In: intact RNA. Out: sequencing-ready library. |
| Pore translocation | strands pass through protein pores | In: library. Out: ionic-current traces. |
| Live basecalling | current decoded into sequence and modifications | In: current traces. Out: modified-sequence reads. |
| Real-time analysis | assembly and surveillance while sequencing runs | In: reads. Out: genomes, modification maps, alerts. |
| Deployed insight | transcriptomics or environmental monitoring | In: analysis. Out: biological and operational decisions. |
Cross-cutting technologies of the sector:
- Adaptive sampling (Selective Reading): the platform rejects or retains molecules mid-read, steering capacity toward targets of interest.
- Metagenome assembly pipelines (Field-Grade Assembly): nanoMDBG-class assemblers turn noisy metagenomic reads into usable genomes in surveillance settings.
- Diagnostic device compliance (The IVD Edge): CE-IVD and UKCA marking on the GridION Dx configuration separates the research chemistry from the regulated diagnostic device.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Sample to native RNAIntact, full-length RNA is recovered from the biological sample without amplification.
- 2Library preparationFormulation & blendingAdapters are ligated to native strands; an updated cDNA-PCR kit extends the route where RNA input is limited.Who can do this step matched automatically✓ ISO 9001 500 m3“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”15,800 MT industrial scale“Latest 2025-26 development: Sotanala (Alwar, Rajasthan) new formulation facility—first phase expected for upcoming Kharif 2026; expansion in 2 phases incl.”SyAqua Group Thailand“vannamei genetics (broodstock, nauplii, and post-larvae) built on genomic selection/marker-assisted selection plus quantitative genetics (BLUP), with disease resistance screening …”
- 3Pore flow cellThe library loads onto a flow cell; strands translocate through protein pores one molecule at a time. Production capacity exceeds one million flow cells per year at the Harwell plant.
- 4Live basecallingIonic-current traces decode into sequence and modification calls as the read passes — barcode-aware adaptive sampling steers the run mid-flight.
- 5Real-time analysisTesting & analyticsAssembly and surveillance pipelines process reads while the run continues; nanoMDBG-class assembly supports environmental monitoring.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
- 6Deployed insightTranscriptomes, modification maps and surveillance signals become operational output — research findings or environmental alerts.
4 · Who delivers
Matched suppliers (matched automatically)
| AGC Biologics | United States | Producer | active |
| SenseUp GmbH | Germany | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| MGI (BGI Group) | China | Producer | active |
| Rev Genomics | United States | Producer | active |
| Orvion | Netherlands | Research / RTO | active |
| Upfront Chromatography A/S | Denmark | Producer | active |
| Agricultural Research Council (ARC) | South Africa | Research / RTO | active |
| Liying Biotech 粒影生物 | China | Producer | active |
| Avipharm Group | South Africa | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Oxford Nanopore | 🇬🇧 United Kingdom | Nanopore direct RNA chemistry; PromethION/MinION/GridION | 1,314 staff; >1 m flow cells/yr; ISO 13485; GridION Dx CE-IVD/UKCA; adaptive sampling | Commercial |
| Genoscope | 🇫🇷 France | Real-time metagenomic surveillance (nanoMDBG) | MinION/GridION/PromethION fleet; ATLASea €41.3 m; 1,700-core cluster | Research |
5 · Rules & route to market
United States
The direct-RNA ledger record has no US rows yet, so this section records the structural frame rather than vendor claims.
Research-use chemistry, the IVD boundary, no US ledger rows#
- RUO framing: native-RNA transcriptomics runs as research-use chemistry; the FDA research/diagnostic boundary is what a clinical claim would have to cross.
- Ledger gap: no sourced US direct-RNA deployment dossiers exist yet — a screen-wave target.
- Ownership note: the platform company is UK-listed (LSE: ONT); US market presence is not carried in the ledger evidence.
European Union
Europe carries both ends of the ledgered value chain: the UK chemistry owner and the French national deployment.
UK production, French surveillance, regulated edge#
- Oxford Nanopore (Oxford, UK): 1,314 employees; production at the Harwell Campus (Didcot) and the Spectrum facility (Abingdon); more than one million flow cells per year; ISO 13485 manufacturing; GridION Dx marked CE-IVD and UKCA.
- Genoscope (Evry-Courcouronnes, France): the national sequencing centre at the Genopole biocluster; real-time ocean and soil metagenome surveillance on MinION, GridION and PromethION pores; nanoMDBG assembly; €41.3 million ATLASea grant (2024) under CEA, France Génomique and ANR funding; a 1,700-core cluster with 1.5 PB storage.
China
China appears in the ledger evidence as equipment inside a European deployment, not as a direct-RNA ledger row.
CN platforms in the platform mix, no direct-RNA ledger depth#
- MGI DNBSEQ-G400 in the mix: Genoscope’s sequencer fleet pairs Oxford Nanopore pores with Illumina and MGI short-read platforms — a CN-made platform inside the ledgered deployment.
- Ledger gap: no sourced CN direct-RNA dossiers exist yet — a screen-wave target.
6 · Money: tenders & grants
| Grant | Capacity building for extending product lifecycles through repair and refurbishment European Commission · EU | Sep 22, 2027 303 days |
| Grant | Deploying circular systemic solutions through living labs in cities and regions (Circular Cities and Regions … European Commission · EU | Apr 8, 2027 136 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 141 days |
| Grant | Enhancing farmer's profitability and resilience through innovations for diversified crops and value chains European Commission · EU | Sep 23, 2027 304 days |
| Grant | Increasing the resilience of agriculture in water and nutrient-scarce environments through digital innovations European Commission · EU | Sep 23, 2027 304 days |
7 · Tech stack & innovations
The stack runs from one intact RNA sample to one deployed insight — and every stage exists to keep the molecule native.
- Native chemistry (Read What Exists):
- the strand is never copied, so the sequence and its modifications arrive in one measurement.
- case: Oxford Nanopore’s direct-RNA and extended transcriptomic kits on MinION, GridION and PromethION hardware.
- Current-level decoding (Signal as Truth):
- base modifications are read from the ionic-current trace itself, not inferred from a converted copy.
- case: modification-aware basecalling on the platform’s live readout.
- Surveillance-grade analysis (Sequencing as Instrument):
- assembly pipelines sized for field conditions turn streams of reads into monitoring output.
- case: Genoscope’s nanoMDBG metagenome assembly behind its ocean and soil programs.
Sources 2 · 0 independent · 2 producer sites
Producers' own sites 2
- nanoporetech.com · nanoporetech.com · nanoporetech.com · nanoporetech.com producer checked 2026-09-22
- www.france-genomique.org · www.genopole.com · www.genoscope.cns.fr · www.cea.fr · hal-hceres.archives-ouvertes.fr · pmc.ncbi.nlm.nih.gov producer checked 2026-09-22